M1 Polarized Microglia

Introduction

M1 Polarized Microglia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

M1 microglia represent the classically activated, pro-inflammatory phenotype that responds to pathogens and damage signals. They are the effector cells of the innate immune system in the central nervous system (CNS), producing high levels of pro-inflammatory cytokines, chemokines, and reactive nitrogen and oxygen species. M1 polarization is induced by stimuli such as lipopolysaccharide (LPS), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) 1. ^{1Mechanisms underlying inflammation in neurodegeneration2010 · Cell · PMID 22002745Open reference}

The M1/M2 paradigm, though somewhat simplified, provides a useful framework for understanding microglia phenotypic diversity. M1 microglia are characterized by elevated expression of major histocompatibility complex class II (MHC-II) molecules, cluster of differentiation 86 (CD86), and inducible nitric oxide synthase (iNOS), enabling antigen presentation and production of neurotoxic molecules. ^{2Neuroinflammation in Alzheimer's disease2015 · Lancet Neurol · PMID 25792098Open reference}

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: microglial cell (source: Cell Ontology)

  • Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000129)

• OBO Foundry (CL:0000129)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000129)

• OBO Foundry (CL:0000129)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Molecular Markers

M1-polarized microglia express a distinct repertoire of surface markers and secreted molecules:

Signaling Pathways

M1 polarization is driven by several key signaling pathways:

NF-κB Pathway

The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is central to M1 polarization. Toll-like receptor (TLR) engagement activates NF-κB, leading to transcription of pro-inflammatory genes including TNF-α, IL-1β, IL-6, and iNOS 2.

JAK/STAT Pathway

IFN-γ binding to its receptor activates JAK1/STAT1 signaling, promoting transcription of M1-associated genes. STAT1 directly upregulates iNOS and MHC-II expression.

MAPK Pathways

p38 MAPK and JNK pathways contribute to M1 polarization by regulating cytokine production and cellular stress responses.

Functions

M1 microglia perform several critical functions:

Pro-inflammatory Responses

M1 microglia secrete pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-12, IL-18) that coordinate the inflammatory response to pathogens and injury.

Pathogen Clearance

Through phagocytosis and production of antimicrobial molecules, M1 microglia eliminate pathogens and cellular debris.

Antigen Presentation

Express MHC-II molecules allow M1 microglia to present antigens to CD4+ T-cells, bridging innate and adaptive immunity.

Cytotoxicity

Production of nitric oxide (via iNOS), reactive oxygen species (ROS), and reactive nitrogen species (RNS) can be cytotoxic to pathogens but also damage nearby neurons and oligodendrocytes.

Induction of Oxidative Stress

NADPH oxidase (NOX2) and iNOS produce superoxide anion and nitric oxide, respectively, which can combine to form peroxynitrite—a highly damaging reactive nitrogen species.

Role in Neurodegenerative Diseases

Alzheimer’s Disease (AD)

M1 microglia are prominently involved in Alzheimer’s disease pathogenesis. Amyloid-beta (Aβ) plaques and tau pathology activate microglia via TLRs and the NLRP3 inflammasome, driving M1 polarization 3. The resulting chronic neuroinflammation contributes to:

• Synaptic loss and cognitive decline

• Neuronal death in hippocampus and cortical regions

• Progression from mild cognitive impairment (MCI) to AD

• Failure of Aβ clearance mechanisms

Parkinson’s Disease (PD)

In Parkinson’s disease, M1 microglia are activated by α-synuclein aggregates, neuromelanin, and damage-associated molecular patterns (DAMPs). This contributes to:

• Dopaminergic neuron loss in substantia nigra pars compacta

• Neuroinflammation in basal ganglia circuits

• Motor symptom progression

• Propagation of α-synuclein pathology

Amyotrophic Lateral Sclerosis (ALS)

M1 microglia in ALS produce neurotoxic cytokines and oxidative stress that accelerate motor neuron degeneration. Studies show M1 microglial markers correlate with disease progression 4.

Multiple Sclerosis (MS)

M1 microglia contribute to demyelination and lesion formation in MS. They attack myelin sheaths and produce factors that inhibit oligodendrocyte precursor cell (OPC) differentiation and remyelination.

Therapeutic Targeting

Anti-inflammatory Strategies

Repolarization to M2 Phenotype

Promoting the M2 (neuroprotective) phenotype is a promising strategy:

• IL-4/IL-13: Drive M2 polarization via STAT6

• IL-10: Anti-inflammatory cytokine that suppresses M1

• TGF-β: Promotes M2 and tissue repair

• Acetylcholine: Cholinergic anti-inflammatory pathway

NOX2 Inhibitors

Targeting NADPH oxidase to reduce oxidative stress:

• Apocynin: NOX2 assembly inhibitor

• GKT137831: NOX1/NOX4 inhibitor in clinical trials

See Also

• Microglia

• [M2 Polarized Microglia

• Disease-Associated Microglia (DAM)m2-polarized-microglia

• Neuroinflammation

• [TNF-α in Neurodegeneration

](/diseases/tnf-α-in-neurodegeneration)## Background

The study of M1 Polarized Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Pathway Diagram

graph TD
    MICROGLIA["MICROGLIA"] -->|"expressed in"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEURON["NEURON"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TNF["TNF"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| SNCA["SNCA"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TAU["TAU"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"activates"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
    MICROGLIA["MICROGLIA"] -->|"regulates"| Alzheimer["Alzheimer"]
    MICROGLIA["MICROGLIA"] -->|"regulates"| Als["Als"]
    style MICROGLIA fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TREM2 fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEUROINFLAMMATION fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TNF fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style SNCA fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURODEGENERATION fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#333,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
    style Als fill:#ef5350,stroke:#333,color:#e0e0e0